英文名稱 Anti-CD137

中文名稱 腫瘤壞死因子受體超家族成員9抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/100μg 0.2ml/200μg

抗體來(lái)源 Rabbit

交叉反應(yīng) Human, Mouse, Rat, Horse

產(chǎn)品類型 一抗

研究領(lǐng)域 腫瘤 細(xì)胞生物 免疫學(xué) 細(xì)胞凋亡 細(xì)胞膜受體 自然殺傷細(xì)胞 t-淋巴細(xì)胞

蛋白分子量 predicted molecular weight: 25kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humanCD137

亞 型 IgG

純化方法 affinity purified by Protein A

儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件  Store at -20 °C for one year.

別 名 Tumor necrosis factor receptor superfamily member 9;Tnfrsf9; TNFRSF9; 4-1BB; 4 1BB; 4 1BB ligand receptor; Homolog of mouse 4 1BB;Receptor protein 4 1BB; T cell antigen 4 1BB homolog; T cell antigen ILA;Cd137; CDw137; CD 137; CD137 antigen; Induced by lymphocyte activation; ILA;Interleukin activated receptor homolog of mouse Ly63; Ly63; MGC2172; MGC114552;OTTHUMP00000044294; TNR9_HUMAN.